SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-024169
Filing Date
2019-07-01
Accepted
2019-07-01 08:02:37
Documents
3
Period of Report
2019-07-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K phas-8k_20190701.htm 8-K 35510
2 EX-99.1 phas-ex991_6.htm EX-99.1 12428
3 GRAPHIC ggssinrxnoqc000001.jpg GRAPHIC 9524
  Complete submission text file 0001564590-19-024169.txt   62510
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38697 | Film No.: 19931292
SIC: 2834 Pharmaceutical Preparations